News

After a steep share price decline over the past five years, Teladoc Health now screens as cheap on several valuation checks, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model indicating that the stock trades at a discount to that estimate. Teladoc Health shareholders have seen the stock fall 93.9% over the past five years, which means even a modest shift in market expectations can have a large impact on perceived value. The push toward broader virtual care adoption,...

Teladoc Health (NYSE:TDOC) has entered a new partnership with Walmart to embed its virtual care services into Walmart's retail platforms. The collaboration extends Teladoc's reach into both retail and institutional channels through Walmart's broad footprint. The company continues to emphasize a path toward consistent profitability following periods of net losses. Teladoc Health sits at an interesting point, with the stock trading around $9.07 and showing mixed recent performance. The share...

A number of stocks fell in the afternoon session after President Trump declared the Iran ceasefire "over" and vowed to strike again, driving oil higher and bond yields up in a risk-off rotation.

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

It could be an attractive contrarian play, but beware of the risks.

The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.

A number of stocks jumped in the afternoon session after signs of renewed diplomatic talks between the U.S. and Iran boosted investor sentiment.

Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.

Teladoc (TDOC) reached $7.57 at the closing of the latest trading day, reflecting a +1.47% change compared to its last close.

Analyst sentiment shift and near term expectations Teladoc Health (TDOC) is back on investors’ radar after analysts turned more positive in their earnings estimates, even as they still expect a 26.32% year over year decline in the upcoming report. This change in sentiment, paired with a recent 1.44% gain that outperformed key indices, has focused attention on how the company’s virtual care and mental health businesses might shape near term performance. See our latest analysis for Teladoc...

Teladoc (TDOC) reached $7.03 at the closing of the latest trading day, reflecting a +1.44% change compared to its last close.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Teladoc Health delivers virtual care worldwide; a key insider recently exited their stake, according to the latest SEC filing.

TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.

A number of stocks fell in the afternoon session after rising Treasury yields compressed valuations for growth-oriented names as geopolitical uncertainty dulled the advertising outlook.

In late May 2026, Walmart announced that Teladoc Health’s virtual urgent care, dermatology, and nutrition services are now available on its Better Care Services platform, offering both insured and US$89 cash‑pay visits with integrated pharmacy fulfillment across nearly 5,000 locations. This partnership broadens Teladoc’s retail footprint and reinforces its push to meet patients on large consumer platforms, complementing January’s launch of BetterHelp mental health services on Walmart’s care...

Teladoc stock rallies on an extended partnership with Walmart. But TDOC shares remain unattractive to own at current levels.

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to broaden virtual care.

TDOC teams with Walmart to offer virtual urgent care, dermatology and nutrition services, expanding affordable telehealth access nationwide.

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 11.3% in the afternoon session after it announced its virtual care services are now available through Walmart's Better Care Services platform.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Teladoc (NYSE:TDOC) and the rest of the online marketplace stocks fared in Q1.

Teladoc’s Walmart partnership is the latest step in its push to embed its services with retailers and platforms Americans already use.

Teladoc Health Inc (NYSE:TDOC) is one of the best micro and small cap stocks to buy according to Jim Simons’ Renaissance Technologies. On May 1, Jefferies raised its price target Teladoc shares to $6 from $5.20 while keeping a Hold rating on the stock. Even so, the firm’s new price target remains below Teladoc’s current […]

It would be quite the feat for this struggling company.

Teladoc Health (NYSE:TDOC) is reporting flat sales over consecutive years, despite continued investment in its virtual care platform. Average revenue per user has been declining, pointing to weaker consumer monetization and softer engagement levels. Management has focused on broadening services, but this has not translated into stronger top line growth or higher earnings quality. The outlook for the next twelve months remains subdued, highlighting ongoing challenges for the...